The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
|Articles|September 4, 2021
- Extraordinary Healer® Vol. 15
- Volume 15
The Difficult Task of Negotiating With Insurance Carriers
Author(s)Stephen Langford
One oncology nurse helped her patient with cancer by talking with his insurance carriers to provide a drug he needed for treatment.
Advertisement
Sarah Choposko, RN, goes beyond the line of duty to persuade insurance carriers to provide a tier 5 drug that was prescribed by Texas Oncology in Dallas. She and I had to fight tooth and nail throughout enrollment periods of coverage. It has been lifesaving to myself and relief to my family.
Editor’s Note: This is an essay submitted by Stephen Langford for the 2021 Extraordinary Healer Award.
For more news on cancer updates, research and education, don’t forget to
Articles in this issue
almost 5 years ago
Incorporating Empathy and Compassion During Cancer Treatmentalmost 5 years ago
‘A Rock and Gem’ of the Cancer Centeralmost 5 years ago
An Entire Team's Effort to Care for Patients With Canceralmost 5 years ago
Genuine Care and Advice for Patients With Canceralmost 5 years ago
Oncology Nurses Combine Expertise With Compassionalmost 5 years ago
Companionship Helps Patients Feel Less Alone Through Cancer Treatmentalmost 5 years ago
Effective Teamwork Shapes a New Oncology Practicealmost 5 years ago
An Oncology Nurse With a Fun Personality Despite Hectic Situationsabout 5 years ago
The Nurse Who Puts Life on Hold to Connect With Patients With CancerAdvertisement
Related to this article
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
After her sister’s Hodgkin lymphoma diagnosis, remission and relapse, a caregiver reflects on follow-up care, guilt and finding hope between cancer battles.
After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience and finding hope more than a decade later.
The American Society of Hematology published 2026 guidelines for adults with myelofibrosis on Oct. 14, 2026, with 10 recommendations on genetic testing, JAK inhibitors, anemia, transplant referral and aspirin.
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5